<!--

File produced by pipelineRunner package (for JATS 2 SCJATS with pipeline SCJATS)
At: 2025-05-21T08:23:58.156Z

Version        : 1.16.1
Last update    : 2024-08-27
Modified by    : dunnm

-->
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="case-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JCEM Case Rep</journal-id><journal-id journal-id-type="iso-abbrev">JCEM Case Rep</journal-id><journal-id journal-id-type="publisher-id">jcemcr</journal-id><journal-title-group><journal-title>JCEM Case Reports</journal-title></journal-title-group><issn pub-type="epub">2755-1520</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40401176</article-id><article-id pub-id-type="pmc">PMC12093046</article-id><article-id pub-id-type="doi">10.1210/jcemcr/luaf103</article-id><article-id pub-id-type="publisher-id">luaf103</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00010</subject><subject>AcademicSubjects/MED00160</subject><subject>AcademicSubjects/MED00250</subject><subject>AcademicSubjects/MED00300</subject><subject>AcademicSubjects/MED00905</subject></subj-group></article-categories><title-group><article-title>Diabetic Ketoacidosis&#x02013;Associated Brain Injury: A Rare but Serious Complication</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0004-4199-5419</contrib-id><name><surname>Bencharfa</surname><given-names>Bassam</given-names></name><aff>
<institution>Department of Critical Care Medicine, Avicenna Military Hospital</institution>, <addr-line>Marrakech 40000</addr-line>, <country country="MA">Morocco</country></aff><aff>
<institution>B2S Laboratory, Cadi Ayyad University, Faculty of Medicine and Pharmacy</institution>, <addr-line>Marrakech 40000</addr-line>, <country country="MA">Morocco</country></aff></contrib><contrib contrib-type="author"><name><surname>Zegar</surname><given-names>Ilias</given-names></name><aff>
<institution>Department of Critical Care Medicine, Avicenna Military Hospital</institution>, <addr-line>Marrakech 40000</addr-line>, <country country="MA">Morocco</country></aff><aff>
<institution>B2S Laboratory, Cadi Ayyad University, Faculty of Medicine and Pharmacy</institution>, <addr-line>Marrakech 40000</addr-line>, <country country="MA">Morocco</country></aff></contrib><contrib contrib-type="author"><name><surname>Haddouga</surname><given-names>Sara</given-names></name><aff>
<institution>Department of Critical Care Medicine, Avicenna Military Hospital</institution>, <addr-line>Marrakech 40000</addr-line>, <country country="MA">Morocco</country></aff><aff>
<institution>B2S Laboratory, Cadi Ayyad University, Faculty of Medicine and Pharmacy</institution>, <addr-line>Marrakech 40000</addr-line>, <country country="MA">Morocco</country></aff></contrib><contrib contrib-type="author"><name><surname>Kehel</surname><given-names>Kenza</given-names></name><aff>
<institution>Department of Critical Care Medicine, Avicenna Military Hospital</institution>, <addr-line>Marrakech 40000</addr-line>, <country country="MA">Morocco</country></aff><aff>
<institution>B2S Laboratory, Cadi Ayyad University, Faculty of Medicine and Pharmacy</institution>, <addr-line>Marrakech 40000</addr-line>, <country country="MA">Morocco</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9478-2709</contrib-id><name><surname>Belhadj</surname><given-names>Ayoub</given-names></name><aff>
<institution>Department of Critical Care Medicine, Avicenna Military Hospital</institution>, <addr-line>Marrakech 40000</addr-line>, <country country="MA">Morocco</country></aff><aff>
<institution>B2S Laboratory, Cadi Ayyad University, Faculty of Medicine and Pharmacy</institution>, <addr-line>Marrakech 40000</addr-line>, <country country="MA">Morocco</country></aff></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8420-6679</contrib-id><name><surname>Aissaoui</surname><given-names>Younes</given-names></name><aff>
<institution>Department of Critical Care Medicine, Avicenna Military Hospital</institution>, <addr-line>Marrakech 40000</addr-line>, <country country="MA">Morocco</country></aff><aff>
<institution>B2S Laboratory, Cadi Ayyad University, Faculty of Medicine and Pharmacy</institution>, <addr-line>Marrakech 40000</addr-line>, <country country="MA">Morocco</country></aff><xref rid="luaf103-cor1" ref-type="corresp"/><!--younes.aissaoui@uca.ma--></contrib></contrib-group><author-notes><corresp id="luaf103-cor1">
<bold>Correspondence:</bold> Younes Aissaoui, MD, Department of Critical Care Medicine, Avicenna Military Hospital, Marrakech 40000, Morocco. Email: <email>younes.aissaoui@uca.ma</email>.</corresp></author-notes><pub-date pub-type="collection"><month>7</month><year>2025</year></pub-date><pub-date pub-type="epub" iso-8601-date="2025-05-21"><day>21</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>21</day><month>5</month><year>2025</year></pub-date><volume>3</volume><issue>7</issue><elocation-id>luaf103</elocation-id><history><date date-type="received"><day>21</day><month>2</month><year>2025</year></date><date date-type="editorial-decision"><day>24</day><month>4</month><year>2025</year></date><date date-type="corrected-typeset"><day>21</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025. Published by Oxford University Press on behalf of the Endocrine Society.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. See the journal About page for additional terms.</license-p></license></permissions><self-uri xlink:href="luaf103.pdf"/><abstract><title>Abstract</title><p>Diabetic ketoacidosis (DKA)&#x02013;associated brain injury is a rare but serious complication, typically occurring early during metabolic correction and associated with a poor prognosis. We report the case of an 18-year-old college student admitted to the intensive care unit with severe DKA, characterized by profound metabolic acidosis and marked electrolyte imbalances, including hypokalemia, hypernatremia, and hyperchloremia. Within hours, she developed altered mental status and generalized seizures. Brain magnetic resonance imaging (MRI) revealed diffuse cortical and brainstem abnormalities, suggestive of cytotoxic cerebral edema. She was managed with continuous sedation, mechanical ventilation, intravenous insulin, potassium supplementation, enteral nutrition, and gradual metabolic correction. Her neurologic status improved within a few days, and follow-up MRI showed partial regression of the lesions. She was subsequently transferred to the endocrinology department and ultimately regained full cognitive and physical function. This case underscores the importance of early recognition, close neurologic monitoring, timely neuroimaging, and tight metabolic and osmotic control to optimize outcomes in patients with DKA-associated brain injury.</p></abstract><kwd-group><kwd>diabetic ketoacidosis</kwd><kwd>brain injury</kwd><kwd>seizure</kwd><kwd>cerebral edema</kwd><kwd>cerebral hypoperfusion</kwd><kwd>magnetic resonance imaging</kwd></kwd-group><counts><page-count count="5"/></counts></article-meta></front><body><sec sec-type="intro" id="luaf103-s1"><title>Introduction</title><p>Diabetic ketoacidosis (DKA)-associated brain injury is a rare but severe complication that typically occurs within the first few hours of metabolic correction. It is associated with poor outcomes and increased mortality [<xref rid="luaf103-B1" ref-type="bibr">1</xref>]. The most serious neurological manifestation of DKA is cerebral edema (CE), which is well documented in pediatric populations, where it remains the leading cause of death, with a mortality rate of 20% to 25% [<xref rid="luaf103-B2" ref-type="bibr">2</xref>, <xref rid="luaf103-B3" ref-type="bibr">3</xref>]. In contrast, CE is infrequently reported in adults. Its incidence, risk factors, and optimal management remain poorly defined [<xref rid="luaf103-B4" ref-type="bibr">4</xref>].</p><p>Here, we present the case of a young patient with inaugural DKA and profound acidosis who subsequently developed DKA-associated brain injury. We describe the clinical presentation, imaging findings, pathophysiological hypotheses, and therapeutic strategies, emphasizing the importance of early recognition, close monitoring, and timely intervention in improving outcomes for this rare but potentially fatal complication.</p></sec><sec id="luaf103-s2"><title>Case Presentation</title><p>An 18-year-old female college student with a history of chronic polydipsia and polyuria presented with a 1-week history of cough, fever, and pharyngitis. The day prior to admission, she developed recurrent vomiting. She was brought to the emergency department (ED) with altered mental status and respiratory distress.</p><p>On initial evaluation, she was tachycardic (130 beats per min), hypotensive (92/67 mm Hg), and tachypneic (35 breaths per min), with a capillary refill time of 3&#x02005;seconds, sunken eyes, dry mucous membranes, and reduced urine output&#x02014;findings consistent with both extracellular and intracellular dehydration. She was afebrile (36.1 &#x000b0;C), and neurologic assessment revealed a Glasgow Coma Scale (GCS) score of 13/15 (E3, V4, M6), with no focal neurologic deficits.</p></sec><sec id="luaf103-s3"><title>Diagnostic Assessment</title><p>Point-of-care capillary glucose testing revealed severe hyperglycemia greater than 600&#x02005;mg/dL (&#x0003e;33.3&#x02005;mmol/L; normal range: 70-110&#x02005;mg/dL [3.9-6.1&#x02005;mmol/L]). Urine dipstick showed significant ketonuria, and a low venous bicarbonate level of 6&#x02005;mmol/L (normal range: 22-30 mmol/L) confirmed the diagnosis of DKA [<xref rid="luaf103-B5" ref-type="bibr">5</xref>].</p><p>Laboratory results revealed hypernatremia with a serum sodium of 143&#x02005;mmol/L (normal reference range: 136-145&#x02005;mmol/L) and a corrected sodium of 161&#x02005;mmol/L. Additional abnormalities included profound hypokalemia, hyperchloremia, and severe metabolic acidosis. Inflammatory markers were elevated, with leukocytosis and thrombocytosis. Renal function was preserved, with a creatinine of 79&#x02005;&#x000b5;mol/L (8.9&#x02005;mg/dL) (normal range: 60-120&#x02005;&#x000b5;mol/L; 5.7-10.9 mg/dL), and an estimated glomerular filtration rate of 82&#x02005;mL/min/1.73&#x02005;m<sup>2</sup>, calculated using the MDRD (Modification of Diet in Renal Disease) formula (reference: 95 &#x000b1; 20 mL/min/1.73 m&#x000b2;).</p></sec><sec id="luaf103-s4"><title>Treatment</title><p>Initial management in the ED included fluid resuscitation with 1 L of normal saline over the first hour. Following the initial bolus, fluid administration continued at 500&#x02005;mL/h, titrated according to the hemodynamic response. The patient's water deficit was estimated to be approximately 3.7 L using the standard formula. Intravenous insulin therapy was initiated per local protocol, beginning with a 0.1&#x02005;IU/kg bolus followed by a continuous infusion at 0.1&#x02005;IU/kg/h.</p><p>Due to persistent altered mental status, severe metabolic acidosis, and profound hypokalemia (1.8&#x02005;mmol/L; normal reference range: 3.5-4.6&#x02005;mmol/L)&#x02014;likely resulting from a combination of vomiting, osmotic diuresis, and insulin-induced intracellular potassium shift. The patient was transferred to the intensive care unit (ICU). On ICU admission, arterial blood gas analysis on room air revealed severe metabolic acidosis (pH 6.95, bicarbonate 5&#x02005;mmol/L; normal reference range: pH 7.31-7.45, bicarbonate 22-33&#x02005;mmol/L) with respiratory compensation (PaCO<sub>2</sub> 27&#x02005;mm Hg; normal reference range: 35-45&#x02005;mmHg) (<xref rid="luaf103-T1" ref-type="table">Table 1</xref>).</p><table-wrap position="float" id="luaf103-T1"><label>Table 1.</label><caption><p>Evolution of arterial blood gas, electrolytes, and renal function during intensive care unit stay</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="left" rowspan="1" colspan="1">H0</th><th align="left" rowspan="1" colspan="1">H12</th><th align="left" rowspan="1" colspan="1">H24</th><th align="left" rowspan="1" colspan="1">Day 3</th><th align="left" rowspan="1" colspan="1">Day 4</th><th align="left" rowspan="1" colspan="1">Day 9</th><th align="left" rowspan="1" colspan="1">Reference range</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">pH</td><td rowspan="1" colspan="1">
<bold>6.95</bold>
</td><td rowspan="1" colspan="1">
<bold>7.01</bold>
</td><td rowspan="1" colspan="1">
<bold>7.02</bold>
</td><td rowspan="1" colspan="1">
<bold>7.22</bold>
</td><td rowspan="1" colspan="1">7.32</td><td rowspan="1" colspan="1">
<bold>7.47</bold>
</td><td rowspan="1" colspan="1">7.31-7.45</td></tr><tr><td rowspan="1" colspan="1">PaCO<sub>2</sub></td><td rowspan="1" colspan="1">
<bold>27&#x02005;mm Hg</bold>
<break/>
<bold>(3.5&#x02005;kPa)</bold>
</td><td rowspan="1" colspan="1">
<bold>25&#x02005;mm Hg</bold>
<break/>
<bold>(3.3&#x02005;kPa)</bold>
</td><td rowspan="1" colspan="1">
<bold>13&#x02005;mm Hg</bold>
<break/>
<bold>(1.7&#x02005;kPa)</bold>
</td><td rowspan="1" colspan="1">
<bold>21&#x02005;mm Hg</bold>
<break/>
<bold>(2.7&#x02005;kPa)</bold>
</td><td rowspan="1" colspan="1">
<bold>25&#x02005;mm Hg</bold>
<break/>
<bold>(3.3&#x02005;kPa)</bold>
</td><td rowspan="1" colspan="1">
<bold>34&#x02005;mm Hg</bold>
<break/>
<bold>(4.5&#x02005;kPa)</bold>
</td><td rowspan="1" colspan="1">35-45&#x02005;mm Hg<break/>(4.7-6.0&#x02005;kPa)</td></tr><tr><td rowspan="1" colspan="1">PaO<sub>2</sub></td><td rowspan="1" colspan="1">90&#x02005;mm Hg<break/>(11.9&#x02005;kPa)</td><td rowspan="1" colspan="1">
<bold>132&#x02005;mm Hg</bold>
<break/>
<bold>(17.5&#x02005;kPa)</bold>
</td><td rowspan="1" colspan="1">
<bold>140&#x02005;mm Hg</bold>
<break/>
<bold>(18.6&#x02005;kPa)</bold>
</td><td rowspan="1" colspan="1">
<bold>114&#x02005;mm Hg</bold>
<break/>
<bold>(15.1&#x02005;kPa)</bold>
</td><td rowspan="1" colspan="1">
<bold>113&#x02005;mm Hg</bold>
<break/>
<bold>(15.0&#x02005;kPa)</bold>
</td><td rowspan="1" colspan="1">
<bold>160&#x02005;mm Hg</bold>
<break/>
<bold>(21.2&#x02005;kPa)</bold>
</td><td rowspan="1" colspan="1">80-100&#x02005;mm Hg<break/>(10.7-13.3&#x02005;kPa)</td></tr><tr><td rowspan="1" colspan="1">Bicarbonate</td><td rowspan="1" colspan="1">
<bold>5&#x02005;mmol/L</bold>
<break/>
<bold>(5 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>6.3&#x02005;mmol/L</bold>
<break/>
<bold>(6.3 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>5.4&#x02005;mmol/L</bold>
<break/>
<bold>(5.4 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>11.4&#x02005;mmol/L</bold>
<break/>
<bold>(11.4 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>15.6&#x02005;mmol/L</bold>
<break/>
<bold>(15.6 meq/L)</bold>
</td><td rowspan="1" colspan="1">25.8&#x02005;mmol/L<break/>(25.8 meq/L)</td><td rowspan="1" colspan="1">22-33&#x02005;mmol/L<break/>(22-33 meq/L)</td></tr><tr><td rowspan="1" colspan="1">Base excess</td><td rowspan="1" colspan="1">
<bold>&#x02212;25&#x02005;mmol/L</bold>
<break/>
<bold>(&#x02212;25 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>&#x02212;23&#x02005;mmol/L</bold>
<break/>
<bold>(&#x02212;23 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>&#x02212;25&#x02005;mmol/L</bold>
<break/>
<bold>(&#x02212;25 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>&#x02212;17&#x02005;mmol/L</bold>
<break/>
<bold>(&#x02212;17 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>&#x02212;13&#x02005;mmol/L</bold>
<break/>
<bold>(&#x02212;13 meq/L)</bold>
</td><td rowspan="1" colspan="1">1&#x02005;mmol/L<break/>(1 meq/L)</td><td rowspan="1" colspan="1">&#x02212;3.0 to +3.0 mmol/L<break/>&#x02212;3.0 to +3.0 meq/L</td></tr><tr><td rowspan="1" colspan="1">Lactate</td><td rowspan="1" colspan="1">10.8&#x02005;mg/dL<break/>(1.2 mmol/L)</td><td rowspan="1" colspan="1">3.6&#x02005;mg/dL<break/>(0.4&#x02005;mmol/L)</td><td rowspan="1" colspan="1">4.5&#x02005;mg/dL<break/>(0.5&#x02005;mmol/L)</td><td rowspan="1" colspan="1">6.3&#x02005;mg/dL<break/>(0.7&#x02005;mmol/L)</td><td rowspan="1" colspan="1">4.5&#x02005;mg/dL<break/>(0.5&#x02005;mmol/L)</td><td rowspan="1" colspan="1">9.0&#x02005;mg/dL<break/>(1&#x02005;mmol/L)</td><td rowspan="1" colspan="1">4.5-14.4&#x02005;mg/dL<break/>(0.5-1.6&#x02005;mmol/L)</td></tr><tr><td rowspan="1" colspan="1">Hemoglobin</td><td rowspan="1" colspan="1">14.5&#x02005;g/dL</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
<bold>11.7&#x02005;g/dL</bold>
</td><td rowspan="1" colspan="1">
<bold>10.9&#x02005;g/dL</bold>
</td><td rowspan="1" colspan="1">
<bold>8.9&#x02005;g/dL</bold>
</td><td rowspan="1" colspan="1">
<bold>7.3&#x02005;g/dL</bold>
</td><td rowspan="1" colspan="1">13-18&#x02005;g/dL</td></tr><tr><td rowspan="1" colspan="1">Leukocytes</td><td rowspan="1" colspan="1">
<bold>15</bold> &#x000a0;<bold>&#x000d7;</bold> &#x000a0;<bold>10&#x02079;/L</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
<bold>17.8</bold> &#x000a0;<bold>&#x000d7;</bold> &#x000a0;<bold>10&#x02079;/L</bold></td><td rowspan="1" colspan="1">
<bold>25.8</bold> &#x000a0;<bold>&#x000d7;</bold> &#x000a0;<bold>10&#x02079;/L</bold></td><td rowspan="1" colspan="1">
<bold>18.9</bold> &#x000a0;<bold>&#x000d7;</bold> &#x000a0;<bold>10&#x02079;/L</bold></td><td rowspan="1" colspan="1">
<bold>13.9</bold> &#x000a0;<bold>&#x000d7;</bold> &#x000a0;<bold>10&#x02079;/L</bold></td><td rowspan="1" colspan="1">4.00-11.00 &#x000d7; 10&#x02079;/L</td></tr><tr><td rowspan="1" colspan="1">Platelets</td><td rowspan="1" colspan="1">169 &#x000d7; 10&#x02079;/L</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">280 &#x000d7; 10&#x02079;/L</td><td rowspan="1" colspan="1">264 &#x000d7; 10&#x02079;/L</td><td rowspan="1" colspan="1">164 &#x000d7; 10&#x02079;/L</td><td rowspan="1" colspan="1">269 &#x000d7; 10&#x02079;/L</td><td rowspan="1" colspan="1">150-450 &#x000d7; 10&#x02079;/L</td></tr><tr><td rowspan="1" colspan="1">Sodium</td><td rowspan="1" colspan="1">
<bold>153&#x02005;mmol/L</bold>
<break/>
<bold>(153 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>161&#x02005;mmol/L</bold>
<break/>
<bold>(161 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>161&#x02005;mmol/L</bold>
<break/>
<bold>(161 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>160&#x02005;mmol/L</bold>
<break/>
<bold>(160 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>156&#x02005;mmol/L</bold>
<break/>
<bold>(156 meq/L)</bold>
</td><td rowspan="1" colspan="1">145&#x02005;mmol/L<break/>(145 meq/L)</td><td rowspan="1" colspan="1">136-145&#x02005;mmol/L<break/>(136-145 meq/L)</td></tr><tr><td rowspan="1" colspan="1">Potassium</td><td rowspan="1" colspan="1">
<bold>1.7&#x02005;mmol/L</bold>
<break/>
<bold>(1.7 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>1.8&#x02005;mmol/L</bold>
<break/>
<bold>(1.8 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>2.9&#x02005;mmol/L</bold>
<break/>
<bold>(2.9 meq/L)</bold>
</td><td rowspan="1" colspan="1">4.4&#x02005;mmol/L<break/>(4.4 meq/L)</td><td rowspan="1" colspan="1">
<bold>3&#x02005;mmol/L</bold>
<break/>
<bold>(3 meq/L)</bold>
</td><td rowspan="1" colspan="1">4.4&#x02005;mmol/L<break/>(4.4 meq/L)</td><td rowspan="1" colspan="1">3.5-4.6&#x02005;mmol/L<break/>(3.5-4.6 meq/L)</td></tr><tr><td rowspan="1" colspan="1">Chloride</td><td rowspan="1" colspan="1">
<bold>126&#x02005;mmol/L</bold>
<break/>
<bold>(126 meq/L)</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
<bold>140&#x02005;mmol/L</bold>
<break/>
<bold>(140 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>130&#x02005;mmol/L</bold>
<break/>
<bold>(130 meq/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>124&#x02005;mmol/L</bold>
<break/>
<bold>(124 meq/L)</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">97-109&#x02005;mmol/L<break/>(97-109 meq/L)</td></tr><tr><td rowspan="1" colspan="1">Glucose</td><td rowspan="1" colspan="1">
<bold>386&#x02005;mg/dL</bold>
<break/>
<bold>(21.4&#x02005;mmol/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>209&#x02005;mg/dL</bold>
<break/>
<bold>(11.6&#x02005;mmol/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>338&#x02005;mg/dL</bold>
<break/>
<bold>(18.8&#x02005;mmol/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>179&#x02005;mg/dL</bold>
<break/>
<bold>(9.9&#x02005;mmol/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>187&#x02005;mg/dL</bold>
<break/>
<bold>(10.4&#x02005;mmol/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>181&#x02005;mg/dL</bold>
<break/>
<bold>(10.1&#x02005;mmol/L)</bold>
</td><td rowspan="1" colspan="1">&#x0003c;140&#x02005;mg/dL<break/>(&#x0003c;7.8&#x02005;mmol/L)</td></tr><tr><td rowspan="1" colspan="1">C-reactive protein</td><td rowspan="1" colspan="1">
<bold>8.2&#x02005;mg/L</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
<bold>42&#x02005;mg/L</bold>
</td><td rowspan="1" colspan="1">
<bold>54&#x02005;mg/L</bold>
</td><td rowspan="1" colspan="1">
<bold>39&#x02005;mg/L</bold>
</td><td rowspan="1" colspan="1">
<bold>33&#x02005;mg/L</bold>
</td><td rowspan="1" colspan="1">&#x0003c;5&#x02005;mg/L</td></tr><tr><td rowspan="1" colspan="1">Procalcitonin</td><td rowspan="1" colspan="1">
<bold>2.15&#x02005;ng/mL</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
<bold>1.64&#x02005;ng/mL</bold>
</td><td rowspan="1" colspan="1">
<bold>1.15&#x02005;ng/mL</bold>
</td><td rowspan="1" colspan="1">0.4&#x02005;ng/mL</td><td rowspan="1" colspan="1">0.3&#x02005;ng/mL</td><td rowspan="1" colspan="1">&#x0003c;0.5&#x02005;ng/mL</td></tr><tr><td rowspan="1" colspan="1">Creatinine</td><td rowspan="1" colspan="1">
<bold>13.1&#x02005;mg/L</bold>
<break/>
<bold>(116&#x02005;&#x000b5;mol/L)</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
<bold>15.5&#x02005;mg/L</bold>
<break/>
<bold>(137&#x02005;&#x000b5;mol/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>26&#x02005;mg/L</bold>
<break/>
<bold>(230&#x02005;&#x000b5;mol/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>26.6&#x02005;mg/L</bold>
<break/>
<bold>(235&#x02005;&#x000b5;mol/L)</bold>
</td><td rowspan="1" colspan="1">
<bold>18.4&#x02005;mg/L</bold>
<break/>
<bold>(163&#x02005;&#x000b5;mol/L)</bold>
</td><td rowspan="1" colspan="1">5.7-10.2&#x02005;mg/L<break/>(60-120&#x02005;&#x000b5;mol/L)</td></tr><tr><td rowspan="1" colspan="1">BUN</td><td rowspan="1" colspan="1">
<bold>11.6&#x02005;mmol/L</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
<bold>14.2&#x02005;mmol/L</bold>
</td><td rowspan="1" colspan="1">
<bold>15.3&#x02005;mmol/L</bold>
</td><td rowspan="1" colspan="1">
<bold>15&#x02005;mmol/L</bold>
</td><td rowspan="1" colspan="1">
<bold>17&#x02005;mmol/L</bold>
</td><td rowspan="1" colspan="1">2.5-7.5&#x02005;mmol/L</td></tr><tr><td rowspan="1" colspan="1">Urine ketones</td><td rowspan="1" colspan="1">
<bold>8&#x02005;mmol/L</bold>
</td><td rowspan="1" colspan="1">
<bold>4&#x02005;mmol/L</bold>
</td><td rowspan="1" colspan="1">
<bold>1.5&#x02005;mmol/L</bold>
</td><td rowspan="1" colspan="1">&#x0003c;0.5&#x02005;mmol/L</td><td rowspan="1" colspan="1">&#x0003c;0.5&#x02005;mmol/L</td><td rowspan="1" colspan="1">&#x0003c;0.5&#x02005;mmol/L</td><td rowspan="1" colspan="1">&#x0003c;0.5&#x02005;mmol/L</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>Urine ketones were measured semi-quantitatively using Multistix reagent strips and converted to approximate absolute values (mmol/L) based on manufacturer data: negative (&#x0003c;0.5), trace (0.5), small (1.5), moderate (4.0), and large (8.0). Abnormal values shown in bold font. Values in parenthesis are International System of Units (SI).</p></fn><fn id="tblfn2"><p>Abbreviations: BUN, blood urea nitrogen; PaCO<sub>2</sub>, partial pressure of carbon dioxide in arterial blood (mm Hg-kPa); PaO&#x02082;, partial pressure of oxygen in arterial blood (mm Hg-kPa).</p></fn></table-wrap-foot></table-wrap><p>Fluid resuscitation continued in the ICU, guided by cardiac output monitoring using transthoracic echocardiography. Balanced crystalloid (Ringer lactate) was used. In total, the patient received 3.5 L of fluids over the first 36&#x02005;hours&#x02014;2 L of 0.9% saline in the ED and 1.5 L of Ringer lactate in the ICU. Insulin was withheld to avoid worsening hypokalemia. A jugular central venous catheter was placed, and intravenous potassium chloride was administered at 1 g/h. Once potassium levels partially corrected, insulin infusion was resumed at a reduced rate of 0.05&#x02005;IU/kg/h. After resolution of ketosis, fluid therapy was adjusted to a maintenance rate of 30 mL/kg/day using either Ringer lactate or 5% dextrose, depending on glycemia. Enteral nutrition via a nasogastric tube was initiated on day 2 (500 kcal/day) and progressively increased to 1500 kcal/day by day 6.</p><p>A urinary tract infection (UTI) was suspected supported by a positive urine dipstick for nitrites and leukocytes. Empirical antibiotic therapy with ceftriaxone (2&#x02005;g once daily) was initiated. Chest x-ray and abdominal ultrasound ruled out other infectious foci, and blood and urine cultures were obtained. Urinalysis showed a leukocyte count of 10&#x02074; cells/mL; however, urine culture grew fewer than 10&#x000b3; colony-forming units, likely due to prior antibiotic exposure. A UTI was therefore identified as the most likely trigger for DKA.</p><p>A few hours after ICU admission, the patient developed generalized tonic-clonic seizures. She was treated with intravenous midazolam (10&#x02005;mg), followed by a phenobarbital loading dose (500&#x02005;mg over 15&#x02005;minutes). A brain computed tomography (CT) scan showed no acute abnormalities. Due to worsening neurologic status (GCS 8/15), endotracheal intubation and mechanical ventilation were initiated. Continuous sedation with midazolam was started, and propofol was added due to significant ventilator dyssynchrony. A lumbar puncture was also performed, revealing clear cerebrospinal fluid (CSF) with mildly elevated protein (1.2&#x02005;g/L; normal reference range: &#x0003c;0.4&#x02005;g/L), while glucose, chloride, and leukocyte counts remained within normal limits. CSF cultures were negative. Electroencephalography (EEG) demonstrated a flat tracing, likely attributable to deep sedation. Given the unexplained neurologic deterioration, brain magnetic resonance imaging (MRI) was performed and revealed multiple nonsystematized, symmetrical supratentorial lesions in the cortex and brainstem, consistent with cytotoxic cerebral edema of metabolic origin (<xref rid="luaf103-F1" ref-type="fig">Fig. 1</xref>).</p><fig position="float" id="luaf103-F1" fig-type="figure"><label>Figure 1.</label><caption><p>Magnetic resonance imaging (MRI) findings in a patient with diabetic ketoacidosis (DKA)-associated brain injury. A, Axial fluid-attenuated inversion recovery MRI showing cortical and subcortical hyperintensity in the left frontal lobe (arrow), suggestive of cerebral edema or ischemic injury. B, Axial diffusion-weighted imaging showing areas of diffusion restriction (arrows), consistent with cytotoxic edama and potential ischemic injury. C, Axial T1-weighted MRI demonstrating involvement of the brainstem (arrow), which may indicate hypoxic-ischemic injury or osmotic demyelination. D, The brainstem lesions are not enhanced after gadolinium injection. MRI findings were highly suggestive of ischemic pathway for brain damage. The reversible character as well as the rapid clinical recovery confirm the metabolic origin.</p></caption><graphic xlink:href="luaf103f1" position="float"/></fig><p>During her ICU stay, she developed acute kidney injury, likely multifactorial in origin, related to hypovolemia, UTI, and hyperchloremia. The patient also experienced significant hypophosphatemia, attributed to insulin-driven intracellular shifts, osmotic diuresis, and possible respiratory alkalosis [<xref rid="luaf103-B6" ref-type="bibr">6</xref>]. It was treated with intravenous phosphate. A progressive hemoglobin drop was noted in the ICU course, likely due to frequent blood draws, systemic inflammation, and possibly preexisting anemia masked by dehydration.</p></sec><sec id="luaf103-s5"><title>Outcome and Follow-up</title><p>By day 5, the patient&#x02019;s electrolyte imbalances had improved, and with metabolic stabilization, sedation was gradually discontinued, allowing for progressive recovery of consciousness. This enabled successful ventilator weaning and tracheal extubation by day 8.</p><p>A follow-up brain MRI showed persistent cortical and brainstem lesions, though with partial regression on diffusion-weighted imaging sequences. A repeat EEG demonstrated normal background activity and reactivity.</p><p>On day 11, the patient was transferred to the endocrinology department, where she was transitioned to subcutaneous insulin therapy. Acute kidney injury, which had begun to improve during her ICU stay, fully resolved during hospitalization. By day 20, she was discharged in stable condition without any neurological deficits.</p></sec><sec sec-type="discussion" id="luaf103-s6"><title>Discussion</title><p>This case highlights a reversible acute brain injury secondary to inaugural DKA. While well documented in pediatric populations, reports of DKA-associated brain injury in adults remain rare, underscoring the need for increased awareness and early recognition.</p><p>Classically, rapid fluid administration and subsequent shifts in serum osmolality were considered the primary cause of CE in DKA [<xref rid="luaf103-B7" ref-type="bibr">7</xref>]. However, recent evidence indicates that cerebral hypoperfusion and the hyperinflammatory state induced by DKA play a central role in its pathogenesis [<xref rid="luaf103-B3" ref-type="bibr">3</xref>].</p><p>According to the American Diabetes Association, fluid resuscitation in DKA should begin with 0.9% NaCl at 1 to 1.5 L over the first hour to restore intravascular volume [<xref rid="luaf103-B5" ref-type="bibr">5</xref>]. Subsequent fluid choice (0.45% or 0.9% NaCl) depends on the corrected serum sodium. Although hypernatremia was present at admission, normal saline was used initially as it was the only available fluid in the ED. In the ICU, hypernatremia was corrected gradually to minimize the risk of osmotic cerebral injury, as rapid correction can lower plasma osmolality and trigger intracellular fluid shifts, potentially worsening cerebral edema.</p><p>The effect of intravenous fluid administration or abrupt glycemic correction on CE has been explored. A study by Kuppermann et al [<xref rid="luaf103-B8" ref-type="bibr">8</xref>] assessed fluid administration rates and sodium chloride content in children with DKA, concluding that neither significantly influenced neurological outcomes. Similarly, a 2023 study [<xref rid="luaf103-B9" ref-type="bibr">9</xref>] found that even with slow glycemic correction, some patients still developed CE.</p><p>While prospective studies on the pathophysiology of CE in DKA remain limited, Glaser et al [<xref rid="luaf103-B7" ref-type="bibr">7</xref>] identified cerebral hypoperfusion and subsequent reperfusion as key contributors. Hypoperfusion results from reduced cerebral blood flow (CBF), exacerbated by profound hypocapnia. This process likely triggers ischemic injury, which may later progress to vasogenic edema due to increased CBF and blood-brain barrier dysfunction.</p><p>MRI studies provide further insights. One investigation assessed apparent diffusion coefficients (ADCs) as a marker of cerebral perfusion, performing MRIs 12&#x02005;hours after DKA treatment initiation and 14 days later [<xref rid="luaf103-B10" ref-type="bibr">10</xref>]. Findings suggested that vasogenic edema, rather than osmotic cellular swelling, was the predominant mechanism. However, in our case, an MRI performed 24&#x02005;hours after treatment initiation revealed cytotoxic edema with low ADC values, indicating ischemic brain damage rather than vasogenic edema. It has been hypothesized that CBF increases beyond baseline levels following fluid resuscitation, leading to fluid extravasation and subsequent cytotoxic CE [<xref rid="luaf103-B11" ref-type="bibr">11</xref>]. Consequently, we opted for a slow correction of hypocapnia to mitigate further neurological compromise.</p><p>Diffusion MRI revealed signal abnormalities in the frontal, temporal, and insular lobes, while the occipital lobe remained unaffected. These findings align with observational data describing cerebral alterations both in symptomatic and asymptomatic patients [<xref rid="luaf103-B12" ref-type="bibr">12</xref>]. Additionally, ADC and perfusion ratios remained unchanged in posterior brain regions, possibly due to reduced sympathetic innervation and lower autoregulatory capacity of the vertebrobasilar system compared to the carotid circulation [<xref rid="luaf103-B13" ref-type="bibr">13</xref>].</p><p>In pediatric DKA, CE has been linked to factors such as low PaCO<sub>2</sub>, elevated serum urea nitrogen, and bicarbonate administration [<xref rid="luaf103-B7" ref-type="bibr">7</xref>]. In our patient, both low PaCO<sub>2</sub> and increasing urea levels were observed. Severe hypocapnia persisted despite deep sedation, likely due to compensatory hyperventilation from metabolic acidosis, which may have aggravated cerebral hypoperfusion and ischemic injury. These findings support the hypothesis that acidosis-driven hyperventilation contributes to DKA-associated brain injury [<xref rid="luaf103-B14" ref-type="bibr">14</xref>], emphasizing the need for close neurologic and ventilatory monitoring. While these risk factors are well studied in children, their applicability to adults remains uncertain. For instance, although age is not a significant risk factor in pediatric cohorts, Khan et al [<xref rid="luaf103-B4" ref-type="bibr">4</xref>] identified advanced age as a predictor of CE in adults, suggesting potential differences in underlying pathophysiology.</p><p>Neurologic manifestations of DKA-associated brain injury typically include altered mental status, seizures, and signs of increased intracranial pressure [<xref rid="luaf103-B5" ref-type="bibr">5</xref>, <xref rid="luaf103-B7" ref-type="bibr">7</xref>]. In our patient, after seizure onset, a comprehensive work-up was performed. Brain CT ruled out intracranial hypertension or hemorrhage, and lumbar puncture excluded central nervous system infection. MRI revealed symmetrical supratentorial lesions, which were probably responsible for the convulsions. In addition, profound metabolic acidosis and severe hypokalemia may have contributed by lowering the seizure threshold through increased neuronal excitability.</p><p>Management of DKA-associated brain injury centers on correcting metabolic abnormalities while minimizing factors that exacerbate cerebral edema. Gradual fluid resuscitation, careful glycemic control, and close monitoring of serum sodium are essential [<xref rid="luaf103-B8" ref-type="bibr">8</xref>]. Electrolyte imbalances&#x02014;especially hypokalemia and hypernatremia&#x02014;should be corrected cautiously [<xref rid="luaf103-B5" ref-type="bibr">5</xref>, <xref rid="luaf103-B15" ref-type="bibr">15</xref>]. In cases of neurologic deterioration, hyperosmolar therapy with hypertonic saline or mannitol may be considered, though adult data are limited [<xref rid="luaf103-B5" ref-type="bibr">5</xref>, <xref rid="luaf103-B16" ref-type="bibr">16</xref>]. Mechanical ventilation with controlled CO<sub>2</sub> levels can help prevent further cerebral hypoperfusion.</p><p>The prognosis of DKA-associated brain injury depends on the severity of cerebral edema, timeliness of intervention, and degree of metabolic derangement at presentation [<xref rid="luaf103-B7" ref-type="bibr">7</xref>]. Outcomes range from full recovery to lasting neurologic deficits. In our case, the patient demonstrated significant clinical and radiological improvement, reinforcing the potential for recovery with appropriate supportive care. However, given the unpredictable nature of DKA-related neurological complications, long-term follow-up remains crucial.</p><p>DKA-associated brain injury is a rare but potentially life-threatening complication, often driven by cerebral hypoperfusion, ischemia-reperfusion injury, and blood-brain barrier dysfunction. While fluid and metabolic management remain the cornerstones of treatment, close neurological and ventilatory monitoring is essential, particularly in patients with persistent hypocapnia or severe metabolic acidosis. Given the limited data on DKA-related brain injury in adults, further research is needed to refine diagnostic strategies and preventive and therapeutic approaches to improve patient outcomes.</p></sec><sec id="luaf103-s7"><title>Learning Points</title><list list-type="bullet"><list-item><p>Early identification of DKA-associated brain injury and close neurological monitoring are crucial in DKA management to detect early signs of brain injury.</p></list-item><list-item><p>DKA-associated brain injury is likely driven by ischemia-reperfusion mechanisms, leading to blood-brain barrier dysfunction and subsequent cerebral edema.</p></list-item><list-item><p>MRI provides valuable insights into the underlying pathophysiology and helps rule out alternative diagnoses, though it may not always directly influence treatment decisions.</p></list-item><list-item><p>Treatment is nonspecific and relies on progressive correction of metabolic disorders to prevent further neurological deterioration.</p></list-item></list></sec><sec id="luaf103-s8"><title>Contributors</title><p>All authors made individual contributions to authorship. B.B., I.Z., K.K., S.H., A.B., and Y.A. were involved in the diagnosis and management of the patient and manuscript submission. B.B., I.Z., and Y.A. were the leads on the original draft. All authors reviewed and approved the final draft.</p></sec></body><back><sec id="luaf103-s9"><title>Funding</title><p>No public or commercial funding.</p></sec><sec id="luaf103-s10"><title>Disclosures</title><p>None declared.</p></sec><sec id="luaf103-s11"><title>Informed Patient Consent for Publication</title><p>Signed informed consent was obtained from the patient.</p></sec><sec sec-type="data-availability" id="luaf103-s12"><title>Data Availability Statement</title><p>Data sharing is not applicable to this article as no data sets were generated or analyzed during the current study.</p></sec><ref-list id="ref1"><title>References</title><ref id="luaf103-B1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Edge</surname> &#x000a0;<given-names>JA</given-names></string-name>, <string-name><surname>Hawkins</surname> &#x000a0;<given-names>MM</given-names></string-name>, <string-name><surname>Winter</surname> &#x000a0;<given-names>DL</given-names></string-name>, <string-name><surname>Dunger</surname> &#x000a0;<given-names>DB</given-names></string-name></person-group>. <article-title>The risk and outcome of cerebral oedema developing during diabetic ketoacidosis</article-title>. <source>Arch Dis Child</source>. <year>2001</year>;<volume>85</volume>(<issue>1</issue>):<fpage>16</fpage>&#x02010;<lpage>22</lpage>.<pub-id pub-id-type="pmid">11420189</pub-id>
</mixed-citation></ref><ref id="luaf103-B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>King</surname> &#x000a0;<given-names>BR</given-names></string-name>, <string-name><surname>Howard</surname> &#x000a0;<given-names>NJ</given-names></string-name>, <string-name><surname>Verge</surname> &#x000a0;<given-names>CF</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>A diabetes awareness campaign prevents diabetic ketoacidosis in children at their initial presentation with type 1 diabetes</article-title>. <source>Pediatr Diabetes</source>. <year>2012</year>;<volume>13</volume>(<issue>8</issue>):<fpage>647</fpage>&#x02010;<lpage>651</lpage>.<pub-id pub-id-type="pmid">22816992</pub-id>
</mixed-citation></ref><ref id="luaf103-B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wolfsdorf</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Glaser</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Sperling</surname> &#x000a0;<given-names>MA</given-names></string-name>; <collab>American Diabetes Association</collab></person-group>. <article-title>Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American diabetes association</article-title>. <source>Diabetes Care</source>. <year>2006</year>;<volume>29</volume>(<issue>5</issue>):<fpage>1150</fpage>&#x02010;<lpage>1159</lpage>.<pub-id pub-id-type="pmid">16644656</pub-id>
</mixed-citation></ref><ref id="luaf103-B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Khan</surname> &#x000a0;<given-names>V</given-names></string-name>, <string-name><surname>Farooqi</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Shah</surname> &#x000a0;<given-names>H</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Incidence, predictors and outcomes of cerebral edema among patients with diabetic ketoacidosis (DKA) from nationwide inpatient sample (NIS) 2002-2015: 2725</article-title>. <source>Am J Gastroenterol</source>. <year>2018</year>;<volume>113</volume>(<issue>suppl</issue>):<fpage>S1519</fpage>.</mixed-citation></ref><ref id="luaf103-B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Umpierrez</surname> &#x000a0;<given-names>GE</given-names></string-name>, <string-name><surname>Agrawal</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Aranguren</surname> &#x000a0;<given-names>E</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Hyperglycemic crises in adults with diabetes: a consensus report</article-title>. <source>Diabetes Care</source>. <year>2024</year>;<volume>47</volume>(<issue>6</issue>):<fpage>1257</fpage>&#x02010;<lpage>1275</lpage>.<pub-id pub-id-type="pmid">39052901</pub-id>
</mixed-citation></ref><ref id="luaf103-B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kitabchi</surname> &#x000a0;<given-names>AE</given-names></string-name>, <string-name><surname>Umpierrez</surname> &#x000a0;<given-names>GE</given-names></string-name>, <string-name><surname>Miles</surname> &#x000a0;<given-names>JM</given-names></string-name>, <string-name><surname>Fisher</surname> &#x000a0;<given-names>JN</given-names></string-name></person-group>. <article-title>Hyperglycemic crises in adult patients with diabetes</article-title>. <source>Diabetes Care</source>. <year>2009</year>;<volume>32</volume>(<issue>7</issue>):<fpage>1335</fpage>&#x02010;<lpage>1343</lpage>.<pub-id pub-id-type="pmid">19564476</pub-id>
</mixed-citation></ref><ref id="luaf103-B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Glaser</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Barnett</surname> &#x000a0;<given-names>P</given-names></string-name>, <string-name><surname>McCaslin</surname> &#x000a0;<given-names>I</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Risk factors for cerebral edema in children with diabetic ketoacidosis. Pediatric emergency medicine collaborative research committee of the American academy of pediatrics</article-title>. <source>N Engl J Med</source>. <year>2001</year>;<volume>344</volume>(<issue>4</issue>):<fpage>264</fpage>&#x02010;<lpage>269</lpage>.<pub-id pub-id-type="pmid">11172153</pub-id>
</mixed-citation></ref><ref id="luaf103-B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kuppermann</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Ghetti</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Schunk</surname> &#x000a0;<given-names>JE</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis</article-title>. <source>N Engl J Med</source>. <year>2018</year>;<volume>378</volume>(<issue>24</issue>):<fpage>2275</fpage>&#x02010;<lpage>2287</lpage>.<pub-id pub-id-type="pmid">29897851</pub-id>
</mixed-citation></ref><ref id="luaf103-B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ghetti</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Kuppermann</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Trainor</surname> &#x000a0;<given-names>JL</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Neuroimaging and neurologic outcomes in children with diabetic ketoacidosis: the 3D study</article-title>. <source>JAMA Pediatr</source>. <year>2023</year>;<volume>177</volume>(<issue>11</issue>):<fpage>1117</fpage>&#x02010;<lpage>1126</lpage>.<pub-id pub-id-type="pmid">37669068</pub-id>
</mixed-citation></ref><ref id="luaf103-B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Glaser</surname> &#x000a0;<given-names>NS</given-names></string-name>, <string-name><surname>Wootton-Gorges</surname> &#x000a0;<given-names>SL</given-names></string-name>, <string-name><surname>Marcin</surname> &#x000a0;<given-names>JP</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Mechanism of cerebral edema in children with diabetic ketoacidosis</article-title>. <source>J Pediatr</source>. <year>2004</year>;<volume>145</volume>(<issue>2</issue>):<fpage>164</fpage>&#x02010;<lpage>171</lpage>.<pub-id pub-id-type="pmid">15289761</pub-id>
</mixed-citation></ref><ref id="luaf103-B11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Raichle</surname> &#x000a0;<given-names>ME</given-names></string-name>, <string-name><surname>Posner</surname> &#x000a0;<given-names>JB</given-names></string-name>, <string-name><surname>Plum</surname> &#x000a0;<given-names>F</given-names></string-name></person-group>. <article-title>Cerebral blood flow during</article-title>. <source>Arch Neurol</source>. <year>1970</year>;<volume>23</volume>(<issue>5</issue>):<fpage>394</fpage>&#x02010;<lpage>403</lpage>.<pub-id pub-id-type="pmid">5471647</pub-id>
</mixed-citation></ref><ref id="luaf103-B12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Vavilala</surname> &#x000a0;<given-names>MS</given-names></string-name>, <string-name><surname>Richards</surname> &#x000a0;<given-names>TL</given-names></string-name>, <string-name><surname>Roberts</surname> &#x000a0;<given-names>JS</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment</article-title>. <source>Pediatr Crit Care Med</source>. <year>2010</year>;<volume>11</volume>(<issue>3</issue>):<fpage>332</fpage>&#x02010;<lpage>338</lpage>.<pub-id pub-id-type="pmid">19838141</pub-id>
</mixed-citation></ref><ref id="luaf103-B13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Edvinsson</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Owman</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Sj&#x000f6;berg</surname> &#x000a0;<given-names>NO</given-names></string-name></person-group>. <article-title>Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study</article-title>. <source>Brain Res</source>. <year>1976</year>;<volume>115</volume>(<issue>3</issue>):<fpage>377</fpage>&#x02010;<lpage>393</lpage>.<pub-id pub-id-type="pmid">184880</pub-id>
</mixed-citation></ref><ref id="luaf103-B14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Azova</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Rapaport</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Wolfsdorf</surname> &#x000a0;<given-names>J</given-names></string-name></person-group>. <article-title>Brain injury in children with diabetic ketoacidosis: review of the literature and a proposed pathophysiologic pathway for the development of cerebral edema</article-title>. <source>Pediatr Diabetes</source>. <year>2021</year>;<volume>22</volume>(<issue>2</issue>):<fpage>148</fpage>&#x02010;<lpage>160</lpage>.<pub-id pub-id-type="pmid">33197066</pub-id>
</mixed-citation></ref><ref id="luaf103-B15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Silver</surname> &#x000a0;<given-names>SM</given-names></string-name>, <string-name><surname>Clark</surname> &#x000a0;<given-names>EC</given-names></string-name>, <string-name><surname>Schroeder</surname> &#x000a0;<given-names>BM</given-names></string-name>, <string-name><surname>Sterns</surname> &#x000a0;<given-names>RH</given-names></string-name></person-group>. <article-title>Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis</article-title>. <source>Kidney Int</source>. <year>1997</year>;<volume>51</volume>(<issue>4</issue>):<fpage>1237</fpage>&#x02010;<lpage>1244</lpage>.<pub-id pub-id-type="pmid">9083292</pub-id>
</mixed-citation></ref><ref id="luaf103-B16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Decourcey</surname> &#x000a0;<given-names>DD</given-names></string-name>, <string-name><surname>Steil</surname> &#x000a0;<given-names>GM</given-names></string-name>, <string-name><surname>Wypij</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Agus</surname> &#x000a0;<given-names>MS</given-names></string-name></person-group>. <article-title>Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality</article-title>. <source>Pediatr Crit Care Med</source>. <year>2013</year>;<volume>14</volume>(<issue>7</issue>):<fpage>694</fpage>&#x02010;<lpage>700</lpage>.<pub-id pub-id-type="pmid">23863818</pub-id>
</mixed-citation></ref></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>ADCs</term><def><p>apparent diffusion coefficients</p></def></def-item><def-item><term>CBF</term><def><p>cerebral blood flow</p></def></def-item><def-item><term>CE</term><def><p>cerebral edema</p></def></def-item><def-item><term>CSF</term><def><p>cerebrospinal fluid</p></def></def-item><def-item><term>CT</term><def><p>computed tomography</p></def></def-item><def-item><term>DKA</term><def><p>diabetic ketoacidosis</p></def></def-item><def-item><term>ED</term><def><p>emergency department</p></def></def-item><def-item><term>EEG</term><def><p>electroencephalography</p></def></def-item><def-item><term>GCS</term><def><p>Glasgow Coma Scale</p></def></def-item><def-item><term>ICU</term><def><p>intensive care unit</p></def></def-item><def-item><term>MRI</term><def><p>magnetic resonance imaging</p></def></def-item><def-item><term>UTI</term><def><p>urinary tract infection</p></def></def-item></def-list></glossary></back></article>